Log In (Members Only)
Calendar of Events
TERMS OF USE
Search
Certified Medical Director
Jobs Boards

DEA Issues Statement on Authorized Agents for Schedule III-V Controlled Substances


The Drug Enforcement Administration (DEA) issued a 5-page Statement of Policy on the Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies at http://edocket.access.gpo.gov/2010/pdf/2010-25136.pdf. The DEA Statement provides an example of a written agreement that would confer authority to an agent to act on behalf of an individual practitioner with regard to controlled substance prescriptions. In the Statement, the DEA states "where a DEA-registered individual practitioner has made a valid oral prescription for a controlled substance in Schedules III-V by conveying all the required prescription information to the practitioner's agent, that agent may telephone the pharmacy and convey that prescription information to the pharmacist." This does not apply to Schedule II controlled substances. The Statement adds "An agent may not call in an oral prescription for a Schedule II controlled substance on behalf of a practitioner even in an emergency circumstance."

Individual practitioners may choose to designate and authorize one or more persons at one or more locations within or outside their practice to act as their agent. Likewise, an individual may act as an authorized agent for multiple individual practitioners depending upon the circumstances. A sample agreement designating the agent of practitioner for communicating controlled substance prescriptions to pharmacies is provided in the Statement.

AMDA staff is reviewing the Statement and will publish more details shortly. In addition, AMDA continues to partner with other associations to provide guidance to our respective memberships.

To read the DEA Statement, click here.

Free Resource: Tip Sheet on Controlled Substance Prescribing in LTC

Medical societies seeking to ensure compassionate and high quality care for long term care patients joined together to develop a "Tip Sheet on Prescribing for Controlled Substances in Long Term Care." The document is designed to assist physicians and other prescribers in their efforts to ensure proper controlled substances prescribing in long term care, and deal with aggressive enforcement actions by Drug Enforcement Administration agents. View Tip Sheet

New AMDA Distance Learning Opportunities Now Available Online!

AMDA has expanded its online and distance learning offerings.  Adding live webinars, recorded webcasts and bringing back CME credits on revised CPGs, AMDA's education outreach continues to grow to meet the needs of practitioners in the long term care setting.  Participants can earn both CME credits and CMD credits for these educational activities which are now available to you at the click of a mouse.  This is a fantastic opportunity to get long term care specific education without the need to book flights or take time away from your busy practice.

Recently added CME activities include education on practice management, billing and coding in long term care and revised CPGs on COPD, Heart Failure and Parkinson's Disease in the long term care setting.  Whether you are new to the long term care setting, or if you have year's of long term care practice experience, AMDA has put together these CME activities to keep you up to date on clinical and management areas important to your long term care practice.

Visit AMDA's website today to learn about their expanding offerings in distance education.

Click Here To Learn More and Register